Quamed General Assemble

On Wednesday the 9th of June, QUAMED held its 5th annual meeting. Our reports and plans were all adopted. We are grateful that most of our members could participate and we would like to thank ECHO and the Global Fund for their inspiring presentations. With frank exchanges and constructive questions, we feel that we are one step ...

Pharmaceutical Patents and Monopolistic Pricing

South Africa’s struggle to increase access to anti-retroviral medications decades ago focused attention on the relationship between patent protection and high medicine prices. The COVID-19 pandemic has drawn greater attention to the cost of pharmaceutical technologies and the inequitable access to these. Globally this has raised concerns about the impact of the 1994 World Trade ...

Quamed

Notice to QUAMED members and partners

Dear members, As we near our GA meeting set on the 9th June 2021, we’d like to kindly remind you all that it is crucial to check out our latest newsletter with the membership folder that includes all the important documents you’ll need for voting. As it is a statutory requirement, be sure to check it ...

Social and ethical issues of poor quality and misuse of medical products: a special issue of BMJ Global Health

We are pleased to share with you the link to the first articles recently published on BMJ Global Health on ‘The social and ethical problems of poor quality and misuse of medical products’   (https://gh.bmj.com/content/6/Suppl_3/) This issue includes a “hands-on” manuscript by Katherine Enright: Elusive quality: the ethical challenges and dilemmas facing international non-governmental organizations in the ...

[e-med] The role of the pharmacist around the world (RFI)

Podcast: [e-med] The role of the pharmacist around the world (RFI)Duration: 50 minutesBy: Caroline ParéListen here Around the world, the role of the pharmacist differs according to the continents. We take a look at three countries: the United States, France and Cameroon.In the United States, Walmart, owner of a vast network of pharmacies, is under ...

Fighting poor quality health products in times of Covid-19 and beyond: the need for a multi-stakeholder approach

World Health Organization (WHO) estimates from 2017 indicates that 10.5% of medical products available in low- and middle-income countries (LMICs) are “substandard or falsified” (SF). Substandard health products are approved by the national regulators, but they do not comply with adequate standards due to undetected errors, negligence, or poor practice in manufacturing, transportation, or storage. ...

Collaboration of Quamed with Mauritanian Health Ministry

Jean-Christophe Pelissier meets with Minister of Health Minister Hon. Dr. Mohamed Nedhirou Hamed in the light of our collaboration to introduce good pharmaceutical practices in Mauritania. This will be done through: Phase 1: An inventory of private and public wholesalers based on the WHO MQAS and BPDS guidelines Phase 2: A proposal for specifications that ...

WHO on new guidance to promote Strong, Efficient and Sustainable Regulatory Systems

29 April 2021 Departmental news Reading time: 2 min (546 words) The World Health Organization, (WHO) has recently published two documents that will be critical for countries’ regulatory system strengthening activities, including regulatory cooperation, convergence and transparency. Good Regulatory Practices (GRP) and Good Reliance Practices (GReP), published as Annexes 10 and 11 in the 55th report of the WHO Expert ...